Petilorphan combination injection LD, produced by Takeda Pharmaceutical, is an injectable medication combining pethidine hydrochloride and levallorphan tartrate. Identified by YJ code 8219502A1036 and standard 1mL 1 tube, it is a synthetic narcotic used for analgesia, sedation, and spasmolysis in severe pain, as well as for preanesthetic purposes and as an anesthesia adjuvant.
Petilorphan combination injection LD
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).